secwatch / observer
8-K filed January 27, 2023, 6:59 PM ET ticker HCA CIK 0000860730
earnings confidence high sentiment positive materiality 0.85

HCA Healthcare Q4 net income $2.08B ($7.28 EPS); revenue $15.5B; new $3B buyback

HCA Healthcare, Inc.

2022-FY EPS reported $19.15 revenue$60,233,000,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

HCA Healthcare, Inc. reported fourth quarter ended December 31, 2022 results: revenue $15.497 billion, net income $2.081 billion, EPS $7.28 per diluted share. Guidance initiated.

Period
fourth quarter ended December 31, 2022
Revenue
$15.497 billion
Net income
$2.081 billion
EPS
$7.28 per diluted share
Guidance
initiated
Result
reported results
Exact text from the filing
results for the fourth quarter ended December 31, 2022. Key fourth quarter metrics (all percentage changes compare 4Q 2022 to 4Q 2021 unless otherwise noted): ● Revenues totaled $15.497 billion ● Net income attributable to HCA Healthcare, Inc. totaled $2.081 billion, or $7.28 per diluted share ● Adjusted EBITDA totaled $3.179 billion ● Cash flows from operating
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.95

HCA Healthcare, Inc. reported year ended December 31, 2022 results: revenue $60.233 billion, net income $5.643 billion, EPS $19.15 per diluted share. Guidance initiated.

Period
year ended December 31, 2022
Revenue
$60.233 billion
Net income
$5.643 billion
EPS
$19.15 per diluted share
Guidance
initiated
Result
reported results
Exact text from the filing
Revenues for the year ended December 31, 2022 totaled $60.233 billion, compared to $58.752 billion in the same period of 2021.
View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

HCA Healthcare, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-23-016833
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.